Does higher hs-CRP with a high AA/EPA ratio and low EPA indicate a pro-inflammatory vascular state?

Vascular and endothelial mechanisms

• A high arachidonic acid to eicosapentaenoic acid (AA/EPA) ratio combined with low absolute EPA levels creates an environment where AA outcompetes EPA for cyclooxygenase and lipoxygenase enzymes. This drives the production of highly potent pro-inflammatory eicosanoids, such as prostaglandin E2 and leukotriene B4.
• This lipid imbalance directly impairs vascular health, promoting endothelial dysfunction characterized clinically by reduced flow-mediated dilation (FMD) and a lower reactive hyperemia index (RHI).
• At the molecular level, this pro-inflammatory environment activates the NF-κB pathway, upregulating downstream inflammatory cytokines (IL-1β, IL-6) and key endothelial adhesion molecules (ICAM-1, VCAM-1) to promote leukocyte recruitment. Elevated hs-CRP co-occurs alongside these lipid alterations as a sensitive, systemic indicator of active vascular inflammation.

Atherogenic lipoprotein remodeling

• The pro-inflammatory lipid environment actively drives atherogenic lipoprotein remodeling, shifting LDL distribution away from larger, buoyant phenotypes and toward smaller, denser LDL (sdLDL) particles.
• EPA naturally acts as a membrane-integrated antioxidant that physically inhibits lipid peroxidation. Consequently, a low EPA status and elevated AA/EPA ratio severely compromise this antioxidant protection, leaving sdLDL particles highly susceptible to copper-induced oxidation and accelerating the cascade of plaque formation.

Bottom line

• Elevated hs-CRP, a high AA/EPA ratio, and low EPA function as a synergistic dual-signal of systemic inflammation that promotes vascular endothelial dysfunction, drives adhesion molecule expression, and remodels LDL into highly oxidizable sdLDL.